MedPath

Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Pain Control in the Abdominal Surgery

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
Procedure: Patient controlled analgesia
Procedure: transversus abdominis plane block
Procedure: local infiltration
Registration Number
NCT02029755
Lead Sponsor
Taipei Medical University Hospital
Brief Summary

Postoperative analgesia is an important part of the anesthetic care. According to the recent studies, multimodal analgesia can provide better analgesia \& patient satisfaction with fewer side effect. For example, combining intravenous, intramuscular or oral analgesics with transversus abdominis plane (TAP) block or local anesthetic (LA) infiltration as the multimodal analgesia, can furnish a more effective pain control after the abdominal surgery.

For abdominal surgery, both local infiltration and TAP block target on relieving somatic pain. Local anesthetic wound infiltration is easy to perform with low risk. As the advancement of ultrasound technology, performing the TAP block also becomes easier, safer and more accurate. But whether LA infiltration or TAP block is better for the multimodal analgesia regimen remains unclear.

This study is to compare the postoperative pain score, opioid consumption, side effects, and quality of recovery between these two analgesic methods in patients undergoing abdominal surgery. The investigators hypothesized that TAP block may be more effective than LA infiltration as a part of the multimodal analgesia, and can improve the recovery after the abdominal surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Adult (20~65y/o)
  • American Society of Anesthesiologists (ASA) physical status I~II
  • Patients scheduled for regular abdominal surgery under general anesthesia
Exclusion Criteria
  • ASA physical status ≥ 3
  • Allergy to morphine or local anesthetics
  • Morphine tolerance
  • Drug abuse or addiction
  • Bleeding tendency

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PCA onlyPatient controlled analgesiapostoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
TAP blocktransversus abdominis plane blockpostoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
TAP blockPatient controlled analgesiapostoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Local infiltrationlocal infiltrationpostoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Local infiltrationPatient controlled analgesiapostoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Primary Outcome Measures
NameTimeMethod
Opioid Consumptionpostoperative 48 hour

opioid consumption of the participants will be followed at postoperative 1, 6, 12, 24, 36, 48 hour (up to 48 hours).

Pain Score (NRS: Numerical Rating Scale)postoperative 24 hour dynamic

pain scores of the participants will be followed at postoperative 1, 6, 24, 48 hour (up to 48 hours).

(NRS: from 0 to 10, 0 = no pain, 10 = the worst pain) The higher score idicates the worse outcome.

Secondary Outcome Measures
NameTimeMethod
Sedation Scalepostoperative 1, 6, 24, 48 hour
Nausea and Vomiting Categorical Scorepostoperative 1, 6, 24, 48 hour
Rescue Antiemetics Usepostoperative 1, 6, 12, 24, 36, 48 hour
Time to the First Request of Analgesicsan expected average of 5 days

participants will be followed for the duration of hospital stay

Heart Rate Variabilitypreoperative, postoperative 1 hour and 1 day
Length of Hospital Stayan expected average of 5 days

participants will be followed for the duration of hospital stay

Rescue Analgesic Usepostoperative 1, 6, 12, 24, 36, 48 hour
Time to Flatusan expected average of 5 days

participants will be followed for the duration of hospital stay

Quality of Recovery 40postoperative 48 hour
Prurituspostoperative 1, 6, 24, 48 hour
Number of Participants With Intervention-related Complicationan expected average of 5 days

participants will be followed for the duration of hospital stay

Trial Locations

Locations (1)

Taipei Medical University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath